CULLINAN THERAPEUTICS, INC. (CGEM) Return on equity 2020–2022
CULLINAN THERAPEUTICS, INC. (CGEM) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
20.8%FY2022 · since FY2020: -26.0% → 20.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | 20.8% | +36.2 pp |
| FY2021 | -15.4% | +10.6 pp |
| FY2020 | -26.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More CGEM financial trends
CGEM RevenueCGEM Net incomeCGEM Net marginCGEM Gross profitCGEM Gross marginCGEM Operating incomeCGEM Operating marginCGEM Operating cash flowCGEM Free cash flowCGEM Capital expendituresCGEM Stock buybacksCGEM Dividends paidCGEM Total assetsCGEM Total liabilitiesCGEM Shareholders’ equityCGEM overview →